Nutriband Inc. (NTRB): Price and Financial Metrics
NTRB Price/Volume Stats
| Current price | $7.26 | 52-week high | $11.78 |
| Prev. close | $8.18 | 52-week low | $3.72 |
| Day low | $7.20 | Volume | 56,400 |
| Day high | $8.25 | Avg. volume | 146,353 |
| 50-day MA | $5.84 | Dividend yield | N/A |
| 200-day MA | $5.78 | Market Cap | 80.98M |
NTRB Stock Price Chart Interactive Chart >
Nutriband Inc. (NTRB) Company Bio
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida
NTRB Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NTRB Price Returns
| 1-mo | 25.61% |
| 3-mo | 11.52% |
| 6-mo | 76.21% |
| 1-year | 35.96% |
| 3-year | 90.05% |
| 5-year | -30.86% |
| YTD | 54.14% |
| 2024 | 103.02% |
| 2023 | -35.64% |
| 2022 | -64.24% |
| 2021 | -32.80% |
| 2020 | N/A |